Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
about
Recent progress in pancreatic cancerEmerging concepts in pancreatic cancer medicine: targeting the tumor stromaEndoscopic ultrasonography: Transition towards the future of gastro-intestinal diseasesPancreatic cancer surgery: past, present, and futurePrevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future DirectionsThe Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management ChoicesScreening for pancreatic cancer in familial high-risk individuals: A systematic reviewEvolution and dynamics of pancreatic cancer progressionInherited pancreatic cancer syndromesEarly detection and prevention of pancreatic cancer: is it really possible today?Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future ImplicationsEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerThe Key Role of Calmodulin in KRAS-Driven AdenocarcinomasPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersHuman correlates of provocative questions in pancreatic pathologyEarly detection of sporadic pancreatic cancer: strategic map for innovation--a white paperA Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.Screening for Pancreatic Cancer.MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasmsConsensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.Therapeutic options for the management of pancreatic cancer.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN.Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision makingIncidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?Familial pancreatic cancer: genetic advances.Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarianLiver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms.Prevalence of incidental pancreatic cysts on 3 tesla magnetic resonance.Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation modelCross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
P2860
Q24626346-7402C740-370C-4C62-A9FB-EC816ABB9456Q24627664-3F6F1AD8-CAFB-4192-A327-88053542E696Q26768421-60F3CE0E-3E95-4AAF-BE99-6E8740040702Q26781555-BF55BB53-BD45-42D2-9120-33776DCDC620Q26783953-454EF412-6C7F-4581-8B64-C578686EFE6BQ26796693-83FB9029-BACE-4A20-AE51-29758AF23B7DQ26801172-59027E5A-A4D0-46DF-9E35-4DF91F290542Q26849671-E034C73A-6141-4D34-BC33-F35D3FDE31C7Q26853530-7678FA70-490D-4F8E-A4B9-2797D5C45092Q26865704-F261C767-9257-4B90-9EEC-A456DFC759C1Q26996400-68D8038F-19C6-4338-903B-B29CC4DF7142Q27010209-2CD7EAA8-ABAC-4EBF-8189-0FB6F6631338Q27021883-3BC2D94F-FDF6-4474-A267-8F718A641F41Q27022231-75CC9D49-BB35-4B1B-A810-095F850BB66DQ27023576-77AFC247-D187-4A0D-8B7A-CD6602FE5C1EQ28648456-3E741B7A-2D3D-40BD-A099-514FA1DEFDA7Q30238706-DEB7BF56-9110-44AA-A3E8-30C77A277969Q30240971-EBE9B848-B76B-4BD0-B259-EFA5B864E0D0Q30541314-D14CA3E9-044E-49B5-AA15-AD53310B27A8Q33652032-14374B23-0A4F-4E30-B58D-E84F7B2CDF09Q33665450-C772B081-46B2-40EB-972B-41901899C603Q33821218-4E3DA1CE-B103-4881-952D-23BEE15421BFQ33858586-882E2524-3D35-4643-BC15-D77A30F7822BQ33864374-83A18A3A-8842-470B-A8D9-F23DFCA0B23FQ33970217-31129DF8-4F4D-4A28-90A4-ABC7394C5029Q34093776-6DC420D9-14D1-40B6-B774-58B7084330C1Q34093790-4FFEB5C9-A710-443A-9ED3-7A7A40AC3523Q34167517-093564BF-ABCF-4AA1-9CA9-98C9C15BAAB5Q34438494-940B69D0-DC36-4571-8780-05F4C32B1BEFQ34634961-42E18C18-7401-41BC-85F6-79F2DC6D9238Q34645886-DB5B093F-216E-4A67-B813-72D361A84FACQ34652902-94488D98-BA43-42DA-AD38-73EA76439A00Q34658718-0A983CD8-BBFE-40E1-92EC-00F3BEA01C74Q34945185-6567292C-7B84-4DEE-93E8-00A7355C4605Q35067692-17A19ED4-46FA-4C86-9539-F8A5D04BF429Q35187065-2924A44F-75F7-43B7-A08D-0A03056F9D65Q35208634-2CE45C9B-6D38-4EBB-97F9-2BDE3AF0E588Q35214109-635CD370-6FE0-4C93-81A6-5CE50919EAF3Q35343764-11F65AB9-4B90-4375-A1D5-B05E29C69001Q35498705-45BA7D61-6729-4D43-95FE-63C7B4565054
P2860
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@ast
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@en
type
label
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@ast
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@en
prefLabel
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@ast
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
@en
P2093
P2860
P50
P1433
P1476
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
@en
P2093
Alison P Klein
American Cancer of the Pancreas Screening (CAPS) Consortium
Constance Griffin
Daniel Margolis
Gloria Petersen
Ihab R Kamel
James Farrell
Jeffrey Lee
Jennifer Axilbund
P2860
P304
796-804; quiz e14-5
P356
10.1053/J.GASTRO.2012.01.005
P407
P577
2012-01-12T00:00:00Z